An angiogenic, endothelial-cell-targeted polymeric gene carrier

Molecular Therapy

Volumn 6, Issue 5, 2002, Pages 664-672

  Suh, Wonhee ^a   Han, Sang Oh ^a   Yu, Lei ^a   Kim, Sung Wan ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Angiogenic; Endothelial cell; Gene delivery; Plasmid; Poly(Ethylene glycol); Polyethyleneimine; RGD peptide

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; INTEGRIN; MACROGOL; POLYETHYLENEIMINE; POLYMER; SPACER DNA; ALPHAVBETA5 INTEGRIN; ARGINYL-GLYCYL-ASPARTIC ACID; OLIGOPEPTIDE; PEPTIDE; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL SPECIFICITY; CHROMATIN CONDENSATION; COMPLEX FORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; PHYSICAL CHEMISTRY; PROTEIN BINDING; SURFACE CHARGE; ATOMIC FORCE MICROSCOPY; CELL CULTURE; CHEMISTRY; CYTOLOGY; ENDOTHELIUM; GENE TRANSFER; GENE VECTOR; GENETICS; MASS SPECTROMETRY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMID; REPORTER GENE;

CELLS, CULTURED; ENDOTHELIUM; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; INTEGRIN ALPHAVBETA3; INTEGRINS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ATOMIC FORCE; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; PEPTIDES; PLASMIDS; POLYMERS; RECEPTORS, VITRONECTIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFECTION;

EID: 0036853181     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(02)90721-5     Document Type: Article

References (49)

1. Christiano, R. J., and Roth, J. A. (1995). Molecular conjugates: a targeted gene delivery vector for molecular medicine. J. Mol. Med. 73: 479-486.
2. Suh, W., Chung, J. K., Park, S. H., and Kim, S. W. (2001). Antil-JL1 antibody conjugated poly(L-lysine) for targeted gene delivery to leukemia T cells. J. Control. Rel. 72: 171-178.
3. Choi, Y. H., Liu, F., Park, J. S., and Kim, S. W. (1998). Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-targeted gene carrier. Bioconjug. Chem. 9: 708-718.
4. Benns, J. M., Maheshwari, A., Furgeson, D. Y., Mahato, M. I., and Kim, S. W. (2001). Folate-PEG-folate-graft-polyethyleneimine-based gene delivery. J. Drug Target. 9: 123-139.
5. Kim, J. S., Maruyama, A., Akaike, T., and Kim, S. W. (1998). Terplex DNA delivery system as a gene carrier. Pharm. Res. 15: 116-121.
6. Brooks, P. C., Clark, R. A., and Cheresh, D. A. (1994). Requirement of vascular integrin αvβ3 for angiogenesis. Science 264: 569-571.
7. Sipkins, D. A., et al. (1998). Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging. Nat. Med. 4: 623-626.
8. Gasparini, G., et al. (1998). Vascular integrin αvβ3: a new prognostic indicator in breast cancer. Clin. Cancer Res. 4: 2625-2634.
9. 5 are expressed by endothelium of high-risk neuroblastoma and their inhibitions is associated with increased endogeneous ceramide. Cancer Res. 60: 712-721.
10. Hood, J. D., et al. (2002). Tumor regression by targeted gene delivery to the neovasculature. Science 296: 2404-2407.
11. Boussif, O., et al. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine. Proc. Natl. Acad. Sci. USA 92: 7297-7301.
12. Abdallah, B., et al. (1996). A powerful non-viral vector for in vivo gene transfer into the adult mammalian brain: polyethyleneimine. Hum. Gene Ther. 7: 1947-1954.
13. Koivunen, E., Wang, B., and Ruoslahti, E. (1995). Phase libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology 13: 265-270.
14. Howlett, A. R. (1999). Integrin Protocols in Methods in Molecular Biology. Humana Press, Totowa.
15. Ruoslahti, E., Hayman, E. G., Pierschbacher, M., and Engvall, E. (1982). Fibronectin: Purification, immunochemical properties and biological activities. Methods Enzymol. 82: 803-831.
16. Kopecek, J., Kopecekova, P., and Rathi, R. C. (1997). Biorecognition of sugar containing N-(2-hydroxypropyl)methacrylamide copolymers by immobilized lectin. Macromol. Chem. Phys. 198: 1165-1180.
17. Ulbrich, K., Konak, C., Tuzar, Z., and Kopecek, J. (1987). Solution properties of drug carrier based on poly[N-2-hydroxypropyl)methacrylamide] containing biodegradable bonds. Makromol. Chem. 188: 1261-1272.
18. Kopecek, J., Kopecekova, P., and Konak, C. (1997). Biorecognizable polymers: design, structure, and bioactivity. J. M. S. Pure Appl. Chem. A34: 2103-2117.
19. Konak, C., Rathi, R., Kopecekova, P., and Kopecek, J. (1993). Effect of side chains on solution properties of N-(hydroxypropyl)acrylamide copolymers in aqueous solvents. Polymer 34: 4767-4773.
20. Allen, T. M. (1994). Long circulating (sterically stabilised) liposomes for targeteddrug delivery. Trends Pharmacol. Sci. 15: 215-220.
21. Lasic, D. D., and Papahadjopoulos, D. (1995). Liposomes revisited. Science 267: 1275-1276.
22. Lemieux, P., et al. (2000). Block and graft copolymers and nanogel copolymer networks for DNA delivery into cell. J Drug Target. 8: 91-105.
23. Erbacher, P., et al. (1999) Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethyleneimines (PEI). J. Gene Med. 1: 210-222.
24. Senger, D. R., et al. (1999). Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the αvβ3 integrin, osteopontin, and thrombin. Am. J. Pathol. 149: 293-305.
25. Swelick, R. A., et al. (1992). Expression and modulation of the vitronectin receptor on human dermal microvascular endothelial cells. J. Invest. Dermatol. 99: 715-722.
26. Choi, Y. H., et al. (1998). Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. J. Control. Rel. 54: 39-48.
27. Nguyen, H. K., et al. (2000). Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 7: 126-138.
28. Erbacher, P., Remy, J. S., and Behr, J. P. (1999). Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. 6: 138-145.
29. Mislick, K. A., and Baldeschwieler, J. D. (1996). Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA 93: 12349-12354.
30. Folkman, J. (1971). Tumor angiogenesis:therapeutic implications. N. Engl. J. Med. 285: 1182-1186.
31. Folkman, J. (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann. Surg. 175: 409-416.
32. Snyder, S. L., and Sobocinski, P. Z. (1975). An improved 2, 4, 6-trinitrobenzenesulfonic acid method for the determination of amines. Anal. Biochem. 64: 284-288.
33. Pasqualini, R., Koivunen, E., and Ruoslahti, E. (1997). αv integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 15: 542-546.
34. Arap, W., Pasqualini, R., and Ruoslahti, E. (1998). Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279: 377-380.
35. Isberg, R. R. (1991). Discrimination between intracellular uptake and surface adhesion of bacterial pathogens. Science 252: 934-938.
36. Tanner, F. C., Carr, D. P., Nabel, G. J., and Nabel, E. G. (1997). Transfection of human endothelial cells. Cardiovasc Res. 35: 522-528.
37. Kaiser, S., and Toborek, M. (2001). Liposome-mediated high-efficiency transfection of human endothelial cells. J. Vasc. Res. 38: 133-143.
38. Wolfert, M. A., et al. (1996). Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. Hum Gene Ther. 7: 2123-2133.
39. Katayose, S., and Kataoka, K. (1996). PEG-polylysine block copolymer as a novel type of synthetic gene vector with supramolecular structure. Proceed. Intern. Symp. Control. Rel. Bioact. Mat. 23: 899-900.
40. Ouipicky, D., et al. (2000). Steric stabilization of poly-L-lysine/DNA complexes by the covalent attachment of semitelechelic poly[N-(2-hyroxyproppyl)methacrylamide]. Bioconjug. Chem. 11: 492-501.
41. Tocheva, V., et al. (1998). Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. Biochim. Biophys. Acta. Gen. Rev. 1380: 354-368.
42. Nguyen, H. K., et al. (2000). Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 7: 126-138.
43. Ogris, M., Brunner, S., Schuller, S., Kircheis, R., and Wagner, E. (1999). PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6: 596-605.
44. Kong, H.-L., and Crystal, R. G. (1998). Gene therapy strategies for tumor antigangiogenesis. J. Natl. Cancer Inst. 90: 273-286.
45. Sedlacek, H. H. (2001). Pharmacological aspects of targeting cancer gene therapy to endothelial cells. Crit. Rev. Oncol. Hematol. 37: 169-215.
46. Kircheis, R., et al. (1999). Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med. 1: 111-120.
47. Fenske, D. B., MacLachlan, I., and Cullis, P. R. (2002). Stabilized plasmid-lipid particles: a systemic gene therapy vector. Methods Enzymol. 346: 36-71.
48. Anwer, K., Kao, G., Proctor, B., Rolland, A., and Sullivan, S. (2000). Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions. J. Drug Target. 8: 125-135.
49. Howard, K. A., et al. (2000). Influence of hydrophilicity of cationic polymers on the biophysical properties of polyelectrolyte complexes formed by self-assembly with DNA. Biochim. Biophys. Acta. 1475: 245-255.